TRCT
ANNX icon

Tower Research Capital (TRC)’s Annexon ANNX Stock Holding History

Tower Research Capital (TRC)’s Portfolio ANNX Stock Details ANNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.2K Buy
12,677
+10,711
+545% +$60.3K ﹤0.01% 2461
2025
Q4 		$9.87K Sell
1,966
-4,130
-68% -$15.8K ﹤0.01% 3865
2025
Q3 		$18.6K Sell
6,096
-9,462
-61% -$23.5K ﹤0.01% 3377
2025
Q2 		$37.3K Sell
15,558
-10,546
-40% -$21.1K ﹤0.01% 3221
2025
Q1 		$50.4K Buy
26,104
+1,212
+5% +$4.03K ﹤0.01% 2232
2024
Q4 		$128K Buy
24,892
+19,301
+345% +$119K ﹤0.01% 2015
2024
Q3 		$33.1K Sell
5,591
-10,290
-65% -$61K ﹤0.01% 2950
2024
Q2 		$77.8K Buy
15,881
+8,867
+126% +$45.9K ﹤0.01% 2767
2024
Q1 		$50.3K Sell
7,014
-4,910
-41% -$25.5K ﹤0.01% 2272
2023
Q4 		$54.1K Buy
11,924
+4,141
+53% +$10.2K ﹤0.01% 3081
2023
Q3 		$18.4K Buy
7,783
+3,925
+102% +$11.9K ﹤0.01% 3454
2023
Q2 		$13.6K Sell
3,858
-4,134
-52% -$18.1K ﹤0.01% 3755
2023
Q1 		$31K Buy
7,992
+1,903
+31% +$10.5K ﹤0.01% 2945
2022
Q4 		$31K Sell
6,089
-2,336
-28% -$12.8K ﹤0.01% 2706
2022
Q3 		$52K Buy
8,425
+1,772
+27% +$9.58K ﹤0.01% 3123
2022
Q2 		$25K Buy
6,653
+45
+0.7% +$137 ﹤0.01% 3539
2022
Q1 		$18K Buy
6,608
+2,754
+71% +$16.9K ﹤0.01% 3612
2021
Q4 		$44K Buy
3,854
+2,698
+233% +$43.6K ﹤0.01% 2854
2021
Q3 		$22K Sell
1,156
-766
-40% -$15.5K ﹤0.01% 3618
2021
Q2 		$43K Buy
1,922
+551
+40% +$12.2K ﹤0.01% 3140
2021
Q1 		$38K Buy
1,371
+720
+111% +$19.8K ﹤0.01% 3349
2020
Q4 		$16K Sell
651
-1,825
-74% -$47K ﹤0.01% 3996
2020
Q3 		$75K Buy
+2,476
New +$58.1K ﹤0.01% 3349

Other funds holding ANNX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Tower Research Capital (TRC)'s ANNX Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Annexon (ANNX) stake by 545% in Q1 2026, buying an estimated $60.3K and bringing the position to 12,677 shares worth $70.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Tower Research Capital (TRC) first reported a position in ANNX in Q3 2020 and has held it in 23 quarters since. The position peaked at $128K in Q4 2024. 217 funds tracked by Wall St. Rank hold ANNX as of Q1 2026.

  • Tower Research Capital (TRC) held 12,677 shares of Annexon worth $70.2K as of Q1 2026.
  • Tower Research Capital (TRC) bought 10,711 Annexon shares in Q1 2026, an estimated $60.3K.
  • Annexon made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2461 holding.
  • Tower Research Capital (TRC) first reported a position in Annexon in Q3 2020 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s Annexon position peaked at $128K in Q4 2024.
  • 217 funds tracked by Wall St. Rank held Annexon as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.